title: Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection.
abstract: No data are available about the amount of hepatitis B virus (HBV) genomes in liver of patients with chronic HBV infection. The aim of this study was to quantify the intrahepatic HBV DNA in hepatitis B surface antigen (HBsAg)-positive patients with either active or suppressed viral replication and in HBsAg-negative subjects with occult HBV infection. We optimized the Roche "Amplicor HBV Monitor" kit for quantifying liver HBV DNA and analyzed hepatic DNA extracts and serum samples from 19 HBs-Ag-positive and 43 HBsAg-negative individuals. Eight of the HBsAg carriers had active HBV replication, and for 3 of them we analyzed samples obtained before and at the end of 1 year of lamivudine treatment. Five hepatitis Delta virus (HDV) coinfected patients and 6 healthy HBsAg carriers had inhibited HBV activity. Among the HBsAg-negative subjects 21 had occult HBV infection and 22 had no evidence of HBV infection. The median of HBV genomes per microgram of liver DNA milliliter of serum was 34,500 to 2,620,000 in patients with active viral replication, 20,000 to 3,900, 000 before and 10,000 to 2,800 at the end of therapy in lamivudine-treated individuals, 9,800 to 600 in HDV-infected individuals, and 7,450 to 17,400 in healthy HBsAg carriers. These data indicate that cases with suppressed HBV activity, despite the very low levels of viremia, maintain a relatively high amount of intrahepatic viral genomes. This virus reservoir is likely involved in HBV reactivation, which is usually observed after stopping lamivudine treatment. Finally, the analysis of cases with occult HBV infection showed that the assay we used was able to specifically detect and quantify as few as 100 copies of viral genomes per microgram of liver DNA.
authors.affiliation: Dipartimento di Medicina Interna, Università di Messina, Messina, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Cacciola
authors.forename: T
authors.initials: T
authors.lastname: Pollicino
authors.forename: G
authors.initials: G
authors.lastname: Squadrito
authors.forename: G
authors.initials: G
authors.lastname: Cerenzia
authors.forename: D
authors.initials: D
authors.lastname: Villari
authors.forename: R
authors.initials: R
authors.lastname: de Franchis
authors.forename: T
authors.initials: T
authors.lastname: Santantonio
authors.forename: S
authors.initials: S
authors.lastname: Brancatelli
authors.forename: G
authors.initials: G
authors.lastname: Colucci
authors.forename: G
authors.initials: G
authors.lastname: Raimondo
mesh_terms: D000328:Adult; D004279:DNA, Viral / Q000032:analysis*; D005260:Female; D016679:Genome, Viral; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000235:genetics* / Q000276:immunology / Q000821:virology; D006801:Humans; D008099:Liver / Q000276:immunology / Q000378:metabolism* / Q000821:virology; D008297:Male; D008875:Middle Aged
chemical_list: D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens